Viral escape and T cell exhaustion in hepatitis C virus infection analysed using Class I peptide tetramers

被引:47
作者
Kantzanou, M
Lucas, M
Barnes, E
Komatsu, H
Dusheiko, G
Ward, S
Harcourt, G
Klenerman, P
机构
[1] Univ Oxford, Nuffield Dept Med, Oxford OX1 3SY, England
[2] UCL, Royal Free Hosp, Dept Med, London NW3, England
基金
英国医学研究理事会; 英国惠康基金;
关键词
HCV; immune escape; CD8+T lymphocyte; NS3; antigenic variation;
D O I
10.1016/S0165-2478(02)00224-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Hepatitis C virus (HCV) has infected over 170 million people world wide, and in the majority sets up a chronic infection associated with hepatic inflammation. Ho it evades host immunity, particularly CD8+ T cells (CTL) is unclear, but two major factors are likely to operate. viral escape mutation and T cell exhaustion. We have investigated the role of CTL in control of infection during acute disease using Class I peptide tetramers. Although the immune response is quite diverse and numerous epitopes can be targeted, we observe that, especially during acute disease. one epitope (NS3 1073-81) is commonly recognised in HLA-A2 positive individuals. However, the levels of response to this epitope (and others) are very much lower if persistence is established. We examined in detail whether the cause of this low level of reactivity is due to mutation within the epitope. We find that, in fact this epitope is highly conserved during chronic infection, at a clonal level, between individuals, and over time. Thus, although variation within the epitope does occur. lack of reactivity in peripheral blood against this epitope in chronic disease, and loss of control of virus cannot be explained entirely by viral escape. Escape through Mutation probably does play an important role in persistence of HCV, but we also discuss other mechanisms which lead to attenuation of T cell responses which may be important in determining the outcome. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:165 / 171
页数:7
相关论文
共 41 条
[11]   Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS [J].
Goulder, PJR ;
Phillips, RE ;
Colbert, RA ;
McAdam, S ;
Ogg, G ;
Nowak, MA ;
Giangrande, P ;
Luzzi, G ;
Morgan, B ;
Edwards, A ;
McMichael, AJ ;
RowlandJones, S .
NATURE MEDICINE, 1997, 3 (02) :212-217
[12]  
Grabowska AM, 2001, EUR J IMMUNOL, V31, P2388, DOI 10.1002/1521-4141(200108)31:8<2388::AID-IMMU2388>3.0.CO
[13]  
2-L
[14]   Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus [J].
Gruener, NH ;
Lechner, F ;
Jung, MC ;
Diepolder, H ;
Gerlach, T ;
Lauer, G ;
Walker, B ;
Sullivan, J ;
Phillips, R ;
Pape, GR ;
Klenerman, P .
JOURNAL OF VIROLOGY, 2001, 75 (12) :5550-5558
[15]  
HARCOURT G, 2001, J VIRAL HEPATITIS
[16]   Quantitative analysis of hepatitis C virus-specific CD8+ T cells in peripheral blood and liver using peptide-MHC tetramers [J].
He, XS ;
Rehermann, B ;
López-Labrador, FX ;
Boisvert, J ;
Cheung, R ;
Mumm, J ;
Wedemeyer, H ;
Berenguer, M ;
Wright, TL ;
Davis, MM ;
Greenberg, HB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (10) :5692-5697
[17]  
KLENERMAN P, IN PRESS CURR OPINIO
[18]   HLA CLASS I-RESTRICTED CYTOTOXIC T-LYMPHOCYTES SPECIFIC FOR HEPATITIS-C VIRUS - IDENTIFICATION OF MULTIPLE EPITOPES AND CHARACTERIZATION OF PATTERNS OF CYTOKINE RELEASE [J].
KOZIEL, MJ ;
DUDLEY, D ;
AFDHAL, N ;
GRAKOUI, A ;
RICE, CM ;
CHOO, QL ;
HOUGHTON, M ;
WALKER, BD .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (05) :2311-2321
[19]   Medical progress: Hepatitis C virus infection. [J].
Lauer, GM ;
Walker, BD .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (01) :41-52
[20]   Comprehensive analysis of CD8+-T-cell responses against hepatitis C virus reveals multiple unpredicted specificities [J].
Lauer, GM ;
Ouchi, K ;
Chung, RT ;
Nguyen, TN ;
Day, CL ;
Purkis, DR ;
Reiser, M ;
Kim, AY ;
Lucas, M ;
Klenerman, P ;
Walker, BD .
JOURNAL OF VIROLOGY, 2002, 76 (12) :6104-6113